📣 VC round data is live. Check it out!
- Public Comps
- LBX Pharmacy
LBX Pharmacy Valuation Multiples
Discover revenue and EBITDA valuation multiples for LBX Pharmacy and similar public comparables like Selçuk Ecza, Create SD Holdings, AiN Group, Anhui Huaren Health and more.
LBX Pharmacy Overview
About LBX Pharmacy
LBX Pharmacy Chain JSC is a China-based company engages in the sale of medicine and health products. The company is engaged in retailing drugs and other related products, including Chinese and Western medicine, prepared slices of Chinese crude drugs, health equipment, healthy food, and personal care products and life care products. The company is also involved in the wholesale and manufacture of drugs.
Founded
2005
HQ

Employees
N/A
Website
Sectors
Financials (LTM)
EV
$2B
Valuation Multiples
Start free trialLBX Pharmacy Financials
LBX Pharmacy reported last 12-month revenue of $3B and EBITDA of $320M.
In the same LTM period, LBX Pharmacy generated $1B in gross profit, $320M in EBITDA, and $68M in net income.
Revenue (LTM)
LBX Pharmacy P&L
In the most recent fiscal year, LBX Pharmacy reported revenue of $3B and EBITDA of $341M.
LBX Pharmacy is profitable as of last fiscal year, with gross margin of 32%, EBITDA margin of 10%, and net margin of 2%.
Financial data powered by Morningstar, Inc.
LBX Pharmacy Stock Performance
LBX Pharmacy has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
LBX Pharmacy's stock price is $2.05.
LBX Pharmacy share price increased by 0.1% in the last 30 days, and decreased by 26.6% in the last year.
LBX Pharmacy has an EPS (earnings per share) of $0.07.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.0% | 0.1% | -6.5% | -26.6% | $0.07 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLBX Pharmacy Valuation Multiples
LBX Pharmacy trades at 0.5x EV/Revenue multiple, and 5.6x EV/EBITDA.
EV / Revenue (LTM)
LBX Pharmacy Financial Valuation Multiples
As of May 4, 2026, LBX Pharmacy has market cap of $2B and EV of $2B.
LBX Pharmacy has a P/E ratio of 23.0x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified LBX Pharmacy Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


LBX Pharmacy Margins & Growth Rates
LBX Pharmacy grew revenue by 6% but EBITDA decreased by 1% in the last fiscal year.
In the most recent fiscal year, LBX Pharmacy reported gross margin of 32%, EBITDA margin of 10%, and net margin of 2%.
LBX Pharmacy Margins
LBX Pharmacy Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
LBX Pharmacy Operational KPIs
LBX Pharmacy's Rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
LBX Pharmacy's Rule of X is 26% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
LBX Pharmacy Competitors
LBX Pharmacy competitors include Selçuk Ecza, Create SD Holdings, AiN Group, Anhui Huaren Health, Dis-Chem Pharmacies, Omnicell, Redcare Pharmacy, Medplus Health Services, Yixintang Pharmaceutical and Aldawaa Medical Services.
Most LBX Pharmacy public comparables operate across Pharmacies.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.3x | 0.3x | 10.3x | 8.1x | |||
| 0.4x | 0.4x | 6.4x | — | |||
| 0.7x | 0.5x | 9.7x | 6.5x | |||
| 1.6x | — | 13.3x | — | |||
| 0.9x | 0.8x | 11.0x | 10.3x | |||
| 1.6x | 1.6x | 13.6x | 12.9x | |||
| 0.4x | 0.4x | 20.9x | 17.8x | |||
| 1.6x | 1.6x | 20.4x | 18.4x | |||
This data is available for Pro users. Sign up to see all LBX Pharmacy competitors and their valuation data. Start Free Trial | ||||||
LBX Pharmacy Funding History
Before going public, LBX Pharmacy raised $557M in total equity funding, across 1 round.
LBX Pharmacy Funding Rounds
LBX Pharmacy M&A Activity
LBX Pharmacy has acquired 1 company to date.
Last acquisition by LBX Pharmacy was on December 11th 2021. LBX Pharmacy acquired Huairen Health for $324M (EV/Revenue multiple of ).
Latest Acquisitions by LBX Pharmacy
| Description | Huairen Health is a pharmaceutical wholesaler and retailer under HNY Y Group, operating nationwide in China via hnyygroup.com. It distributes prescription drugs, medical supplies, and OTC products through a network of pharmacies and hospitals in Henan Province. |
| HQ Country | |
| HQ City | Huaihua |
| Deal Date | 11 Dec 2021 |
| Valuation | $324M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all LBX Pharmacy acquisitions and their M&A valuation multiples. Start Free Trial | |
LBX Pharmacy Investment Activity
LBX Pharmacy has invested in 1 company to date.
Latest investment by LBX Pharmacy was on July 24th 2017. LBX Pharmacy invested in BAI JIA HUI SU HE PHARMACY in their $400K Angel round (EV/Revenue multiple of ).
Latest Investments by LBX Pharmacy
| Description | BAI JIA HUI SU HE PHARMACY is a retail pharmacy chain operating in Jiangsu Province, China. The network provides prescription medications, over-the-counter drugs, health supplements, and medical devices through physical stores and online channels. |
| HQ Country | |
| HQ City | Suzhou |
| Deal Date | 24 Jul 2017 |
| Round | Angel |
| Raised | $400K |
| Investors | LBX Pharmacy |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all LBX Pharmacy investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout LBX Pharmacy
| When was LBX Pharmacy founded? | LBX Pharmacy was founded in 2005. |
| Where is LBX Pharmacy headquartered? | LBX Pharmacy is headquartered in China. |
| Is LBX Pharmacy publicly listed? | Yes, LBX Pharmacy is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of LBX Pharmacy? | LBX Pharmacy trades under 603883 ticker. |
| When did LBX Pharmacy go public? | LBX Pharmacy went public in 2015. |
| Who are competitors of LBX Pharmacy? | LBX Pharmacy main competitors include Selçuk Ecza, Create SD Holdings, AiN Group, Anhui Huaren Health, Dis-Chem Pharmacies, Omnicell, Redcare Pharmacy, Medplus Health Services, Yixintang Pharmaceutical, Aldawaa Medical Services. |
| What is the current market cap of LBX Pharmacy? | LBX Pharmacy's current market cap is $2B. |
| What is the current revenue of LBX Pharmacy? | LBX Pharmacy's last 12 months revenue is $3B. |
| What is the current revenue growth of LBX Pharmacy? | LBX Pharmacy revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of LBX Pharmacy? | Current revenue multiple of LBX Pharmacy is 0.5x. |
| Is LBX Pharmacy profitable? | Yes, LBX Pharmacy is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of LBX Pharmacy? | LBX Pharmacy's last 12 months EBITDA is $320M. |
| What is LBX Pharmacy's EBITDA margin? | LBX Pharmacy's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of LBX Pharmacy? | Current EBITDA multiple of LBX Pharmacy is 5.6x. |
| What is the current FCF of LBX Pharmacy? | LBX Pharmacy's last 12 months FCF is $204M. |
| What is LBX Pharmacy's FCF margin? | LBX Pharmacy's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of LBX Pharmacy? | Current FCF multiple of LBX Pharmacy is 8.8x. |
| How many companies LBX Pharmacy has acquired to date? | As of May 2026, LBX Pharmacy has acquired 1 company. |
| What was the largest acquisition by LBX Pharmacy? | $324M acquisition of Huairen Health on 11th December 2021 was the largest M&A LBX Pharmacy has done to date. |
| What companies LBX Pharmacy acquired? | LBX Pharmacy acquired Huairen Health. |
| In how many companies LBX Pharmacy has invested to date? | As of May 2026, LBX Pharmacy has invested in 1 company. |
| What was the last LBX Pharmacy investment? | On 24th July 2017 LBX Pharmacy invested in BAI JIA HUI SU HE PHARMACY, participating in a $400K Angel round. |
| In what companies LBX Pharmacy invested in? | LBX Pharmacy invested in BAI JIA HUI SU HE PHARMACY. |
See public comps similar to LBX Pharmacy
Lists including LBX Pharmacy
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
